Diamond and Silk Testify Before Congress
on Social Media
Diamond and Silk Testify Before Congress
on Social Media Censorship Against Conservatives
< >
Diamond and Silk testified before Congress over social media censorship against conservatives, Thursday, with Diamond declaring during their testimony that “censorship is no hoax.”
“We would like to thank the judiciary committee for allowing us the opportunity to voice our concerns about conservatives being targeted and censored on social media platforms,” opened Lynette Hardaway, who is better known as Diamond. “Facebook along with other social media sites have taken aggressive actions to silence conservative voices such as ourselves by deliberately restricting and weaponizing our page with algorithms that censored and suppress our free speech. These bias algorithms are tactics designed to pick up on keywords, thus telling the pages how to behave in ways that repress and stifle expressed ideas including shadow-banning, which blocked our content from being seen by our follower while depriving our brand through the demonetization of our videos.”
“Followers stop receiving notifications when we posted videos & content. Followers were also mysteriously unliked from our page. Subtle and slowly Facebook used one mechanism at a time to diminish our reach by restricting our page so that our 1.2 million followers would not see our content thus silencing our conservative voices,” she continued. “When we reached out to Facebook for an explanation, they gave us the runaround. Mark Zuckerberg testified before Congress and stated that the most important thing he cared about was making sure no one interferes in the 2018 elections. But after doing our research we wondered if Mark Zuckerberg was using Facebook to interfere in the 2018 elections by labeling users accounts as either Liberal, Very Liberal, Moderate, Conservative, or Very Conservative.”
“This is one of the main underhanded ways to censor conservatives. So if I’m labeled as Very Liberal without the option to edit it, update and correct this setting, then algorithms are already put into place which allows advertisers that have Liberal views, services & causes to target me,” Hardaway explained, before adding that, “Diamond and Silk’s personal Facebook page has been labeled by Facebook as Very Liberal.”
Hardaway then declared that, “Even though we are not Very Liberal, Facebook do no not give us the option to change this label to Conservative, making it less likely for us to see advertisement, news stories and services from a conservative point of view,” before asking, “If Facebook labeled our user account as very liberal and got it wrong, how many more other users account have they gotten wrong?”
Pointing to a screenshot of a Facebook notification which informed Diamond and Silk that restrictions had been placed on their Facebook page, and then to screenshots of their followers complaining that they can’t see their videos, Hardaway proclaimed, “They’re not receiving notification… They can’t watch our videos.”
Hardaway also showed screenshots comparing the number of views they used to get on videos compared to now, noting that anti-Trump pages with half the amount of followers were able to rack up hundreds of thousands of views, while Diamond and Silk’s views had dropped to just thousands.
“In 2016 with less than one million followers, our page reach would garner between 5 to 8 million people reached within a week. All of that changed when algorithms were placed on our page to suppress our reach,” she expressed, claiming that “YouTube also demonetized 95 percent of our videos in August of 2017 and categorized our videos as ‘hate speech,’ even though our account was in good standing.”
“Mark Zuckerberg said he don’t allow hate speech yet when people say ‘I hate,’ or ‘we hate,’ those people also garner views,” Hardaway explained. “Was it also an enforcement error for 6 months, 29 days, 5 hours, 40 minutes, and 43 seconds of chatting and emailing about the same issue and being told that my issue would be escalated to a Facebook team, the Spam Team, the Technical Team, the Appeal Team, the Internal Team and the Policy Team only to be told on January 8, 2018 that a request was never sent off?”
“Censorship is no hoax, it’s real. It’s wrong for these social media giants to suppress and disregard people by diminishing and denying them their free speech,” she concluded. “If social media is supposed to be a place for all ideas, or to express an idea, then algorithms and tactics should not be in place to suppress some ideas.”
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...
Continue Reading
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...
Continue Reading
Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...
Continue Reading
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue Reading
Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...
Continue Reading
New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...
Continue Reading
A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...
Continue Reading
High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...
Continue Reading
Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...
Continue Reading
Top 5 Most Recently Viewed Articles
YouTube's Action Against Tenet Media Explained YouTube, which is part of Alphabet (NASDAQ: GOOGL), has made a significant move by shutting down the Tenet Media channel, along with four other channels managed by Lauren Chen. This decision comes in response to serious legal actions taken by the U.S. Department of Justice against certain individuals involved in money...
Continue Reading
Important Update for Ardelyx Investors Regarding Class Action Pomerantz LLP has recently informed shareholders about a class action lawsuit involving Ardelyx, Inc. This lawsuit targets both the company and its key officers, alleging violations of federal securities laws. Investors who held Ardelyx securities during a specified timeframe should pay close attention to this...
Continue Reading
Celebrating Derek Bryson Park's Impact on Finance Derek Bryson Park has recently been highlighted by The Enterprise World Magazine as a key figure in the financial industry, a well-deserved recognition for his extensive and impactful career. With three decades of experience, Park continues to innovate in finance, public service, and global diplomacy. Pioneering Leadership...
Continue Reading
Understanding Currency Impacts in Global Trade Dynamics Scott Bessent, a noted figure in finance, is igniting conversations regarding tariffs and trade in recent discussions. All eyes on Wall Street are focused on how these changes influence market dynamics. Initially, any reduction in the U.S. trade deficit with other nations may seem like a significant win for the...
Continue Reading
Pennant Group's Strategic Acquisition Announcement The Pennant Group, Inc. (NASDAQ: PNTG), a prominent holding company in the healthcare industry, recently achieved a significant milestone by acquiring specific operational assets from UnitedHealth Group Incorporated. This notable transaction was made possible due to UnitedHealth’s acquisition of Amedisys Inc., enabling...
Continue Reading